Background: The purpose of this study was to demonstrate the effect of oral nifedipine on maximal resting anal pressure (MRAP) in healthy volunteers and to evaluate its role in the treatment of chronic anal fissure (CAF). Methods: MRAP was measured in 10 healthy volunteers and 10 patients with CAF before and after oral nifedipine (20 mg b.i.d.). Patients were assessed on the first visit and every fortnight for measurement of MRAP, pain scores, blood pressure, pulse rate, healing of the fissure and adverse effects. Treatments were continued until healing had occurred or for up to 8 weeks. Results: MRAP values before and after nifedipine were 73.2 and 49.3 cm H2O, respectively, in healthy volunteers (p < 0.001). Nifedipine caused a reduction in mean MRAP from 105.2 to 74.0 cm H2O (p < 0.001) in patients with CAF. Pain scores were significantly reduced after 2 weeks of treatment with nifedipine (p < 0.001) and continued throughout the treatment period. At the end of the study 6 of the 10 patients treated with nifedipine were deemed to be healed (n = 5) or improved (n = 1). Headache occurred in 1 patient. Conclusion: We conclude that oral nifedipine is effective in reducing MRAP and should become the first-line treatment for CAF.

Keywords:
Nifedipine, Anal fissure, chronic
1.
Khubchandail IT, Reed JF: Sequelae of internal sphincterotomy for chronic fissure in ano. Br J Surg 1989;76:431–434.
2.
Garcia Aguilar J, Belmonte C, Wong WD, Lowry AC, Madoff RD: Open vs. closed sphincterotomy for chronic anal fissure: Long-term results. Dis Colon Rectum 1996;39:440–443.
3.
Lund JN, Scholefield JH: A prospective, randomized double blind, placebo-controlled trial of glyceryl trinitrate ointment treatment in anal fissure. Lancet 1997;349:11–14.
4.
Richard CS, Gregoire R, Plewes EA: Internal sphincterotomy is superior to topical nitroglycerin in the treatment of chronic anal fissure: Results of a randomised controlled trial by the Canadian Colorectal Surgical Trials Group. Dis Colon Rectum 2000;43:1048–1057.
5.
Skinner SA, Polglase AL, Le CT, Winnet JD: Treatment of anal fissure with glyceryl trinitrate in patients referred for surgical management. Aust NZ J Surg 2001;71:218–220.
6.
Pitt J, Dawas K, Dawson PM: Disappointing results of glyceryl trinitrate in the treatment of chronic fissure in-ano in a district general hospital. Colorectal Dis 1999;1:204–206.
7.
Carapeti EA, Kamm MA, Evans BK, Philips R: Topical Diltiazem and bethanechol decrease anal sphincter pressure without side effects. Gut 1999;45:719–722.
8.
Pitt J, Dawson PM, Hallan RI, Boulos PB: A double-blind randomised placebo-controlled trial of oral indoramin to treat chronic anal fissure. Colorectal Dis 2001;3:165–168.
9.
Maria G, Cassetta E, Gul D, Brisinda G, Bentivaglio AR: A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med 1998;338:217–220.
10.
Birisinda G, Maria G, Bentivaglio AR, Cassette E, Gui D, Albanase A: A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 1999;341:65–69.
11.
Cook TA, Brading AF, Mortensen NJM: Differences in contractile properties of anorectal smooth muscle and the effect of calcium channel blockade. Br J Surg 1999;86:70–75.
12.
Cook TA, Brading AF, Mortensen NJM: Effects of nifedipine on anorectal smooth muscle in vitro. Dis Colon Rectum 1999;42:782–787.
13.
Jonard P, Essamri B: Diltiazem and internal anal sphincter: Lancet 1987;i:754.
14.
Cook TA, Humphreys MMF, Mortensen NJM: Oral nifedipine reduces resting anal pressure and heals chronic anal fissure. Br J Surg 1999;86:1269–1273.
15.
Antropoli C, Perrotti P, Rubino M: Nifedipine for local use in conservative treatment of anal fissures: Preliminary results of a multicenter study. Dis Colon Rectum 1999;42:1011–1015.
16.
Knigt JS, Birks M, Farouk R: Topical diltiazem ointment in the treatment of chronic anal fissure. Br J Surg 2000;88:553–556.
17.
Carapeti EA, Kamm MA, Phillips RK: Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects. Dis Colon Rectum 2000;43:1359–1362.
18.
Jonas M, Scholefield JH: Diltiazem is effective treatment for chronic anal fissures (abstract). Dis Colon Rectum 2000;43:A29.
19.
Kennedy ML, Sowter S, Nguyen H, Lubowski DZ: Glyceryl trinitrate ointment for the treatment of chronic anal fissure: Results of a placebo-controlled trial and long term follow-up. Dis Colon Rectum 1999;42:1000–1006.
20.
Loder PB, Kamm MA, Nicholls RJ, Phillips RK: ‘Reversible chemical sphincterotomy’ by local application of glyceryl trinitrate. Br J Surg 1994;81:1386–1389.
21.
Guillemot F, Lone YC, Leroi H, Lamblin MD, Cortot A: Nitroglycerin in situ reduces upper anal canal pressure (letter). Dig Dis Sci 1992;37:155.
22.
Guillemot F, Leroi H, Lone YC, Rousseau CG, Lamblin MD, Cortot A: Action of in situ nitroglycerin on upper anal canal pressure of patients with terminal constipation. A pilot study. Dis Colon Rectum 1993;36:372–376.
23.
Dorfman G, Levitt M, Platell C: Treatment of chronic anal fissure with topical glyceryl trinitrate. Dis Colon Rectum 1999;42:1007–1010.
24.
Kocher HM, Steward M, Leather AJM, Cullen PT: Randomised clinical trial assessing the side-effect of glyceryl trinitrate and diltiazem hydrochloride in the treatment of chronic anal fissure. Br J Surg 2002;89:413–417.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.